New Key Statistics Module, Z-Score and F-Score
NAS:SRPT Key Ratios
| Market Cap $ M | 12,169.49 |
| Enterprise Value $ M | 11,890.05 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | 45.45 |
| Price/Book | 14.05 |
| Price/Sales | 9.63 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 1,243.00 |
| EPS (TTM) $ | -5.83 |
| Beneish M-Score | -1.47 |
| 10-y EBITDA Growth Rate % | -7.80 |
| 5-y EBITDA Growth Rate % | 3.10 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -23.87 |
| EV-to-EBITDA | -26.21 |
| PEG | -- |
| Shares Outstanding M | 94.51 |
| Net Margin (%) | -43.11 |
| Operating Margin % | -21.54 |
| Pre-tax Margin (%) | -41.83 |
| Quick Ratio | 3.45 |
| Current Ratio | 3.95 |
| ROA % (ttm) | -17.08 |
| ROE % (ttm) | -77.39 |
| ROIC % (ttm) | -27.74 |
| Dividend Yield % | -- |
| Altman Z-Score | 1.71 |
SRPT Number of Guru Trades
SRPT Volume of Guru Trades
Gurus Latest Trades with NAS:SRPT
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:SRPT is held by these investors
Total 3
Sarepta Therapeutics Inc Insider Transactions
No Available Data
News about NAS:SRPT
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers